{
    "root": "0fc8c9a3-79bf-4ff9-84bd-3c47d43b953b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Pregabalin",
    "value": "20240820",
    "ingredients": [
        {
            "name": "PREGABALIN",
            "code": "55JG375S6M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64356"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        }
    ],
    "indications": {
        "text": "pregabalin capsules indicated : \u2022 management neuropathic pain associated diabetic peripheral neuropathy \u2022 management postherpetic neuralgia \u2022 adjunctive therapy treatment partial onset seizures patients 17 years age older \u2022 management fibromyalgia \u2022 management neuropathic pain associated spinal cord injury pediatric information approved pfizer 's lyrica ( pregabalin ) capsules oral solution products . however , due pfizer 's marketing exclusivity rights , product labeled pediatric information .",
        "doid_entities": [
            {
                "text": "peripheral neuropathy (DOID:574)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_574"
            },
            {
                "text": "neuropathy (DOID:870)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_870"
            },
            {
                "text": "fibromyalgia (DOID:631)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_631"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 adult , begin dosing 150 mg/day . ( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) \u2022 dosing recommendations : indication dosing regimen maximum dose dpn pain ( 2.2 ) 3 divided doses per day 300 mg/day within 1 week phn ( 2.3 ) 2 3 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day . adjunctive therapy partial-onset seizures adult patients 17 years age older ( 2.4 ) 2 3 divided doses per day maximum dose 600 mg/day . fibromyalgia ( 2.5 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 450 mg/day . neuropathic pain associated spinal cord injury ( 2.6 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day . \u2022 dose adjusted adult patients reduced renal function . ( 2.7 )",
        "doid_entities": [
            {
                "text": "fibromyalgia (DOID:631)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_631"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "75 mg capsules : light peach opaque cap / white opaque body size ' 4 ' hard gelatin capsules imprinted '140 ' cap ' j ' body black ink , filled white white powder . ndc : 71335-1788-4 : 120 capsules bottle ndc : 71335-1788-1 : 30 capsules bottle ndc : 71335-1788-2 : 60 capsules bottle ndc : 71335-1788-3 : 90 capsules bottle * pvc-alu : polyvinyl chloride film aluminium foil , forming web pvc film backing lidding seal aluminum foil . # alu-alu : aluminum-based laminate film , forming lidding material used blister aluminium . storage handling : store 20\u00ba 25\u00bac ( 68\u00ba 77\u00baf ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "pregabalin capsules contraindicated patients known hypersensitivity pregabalin components . angioedema hypersensitivity occurred patients receiving pregabalin therapy [ ( 5.2 ) ] .",
    "indications_original": "Pregabalin capsules are indicated for: \n                     \u2022\u00a0Management of neuropathic pain associated with diabetic peripheral neuropathy \n                     \n                     \u2022\u00a0Management of postherpetic neuralgia \n                     \n                     \n                        \u2022 Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older\n                     \n                     \u2022\u00a0Management of fibromyalgia \n                     \n                     \u2022\u00a0Management of neuropathic pain associated with spinal cord injury \n                     \n                     \n                         Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information.",
    "contraindications_original": "\u2022\u00a0For adult indications, begin dosing at 150 mg/day. ( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) \u2022\u00a0Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN Pain (2.2) 3 divided doses per day 300 mg/day within 1 week PHN (2.3) 2 or 3 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day. Adjunctive Therapy for Partial-Onset Seizures in Adult Patients 17 Years of Age and Older (2.4) 2 or 3 divided doses per day Maximum dose of 600 mg/day. Fibromyalgia (2.5) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 450 mg/day. Neuropathic Pain Associated with Spinal Cord Injury (2.6) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day. \u2022\u00a0Dose should be adjusted in adult patients with reduced renal function. ( 2.7 )",
    "warningsAndPrecautions_original": "75 mg capsules:\n                  \n                  Light peach opaque cap / white opaque body size '4' hard gelatin capsules imprinted with '140' on cap and 'J' on body with black ink, filled with white to off white powder.\n                  NDC: 71335-1788-4: 120 Capsules in a BOTTLE\n                  NDC: 71335-1788-1: 30 Capsules in a BOTTLE\n                  NDC: 71335-1788-2: 60 Capsules in a BOTTLE\n                  NDC: 71335-1788-3: 90 Capsules in a BOTTLE\n                  *PVC-Alu: Polyvinyl Chloride film with Aluminium foil, where forming web is PVC film which has a backing of a lidding seal of aluminum foil.#Alu-Alu: An aluminum-based laminate film, where the forming and lidding material used for blister is Aluminium.\n                  \n                     Storage and Handling:\n                  \n                  Store at 20\u00ba to 25\u00baC (68\u00ba to 77\u00baF) [see USP Controlled Room Temperature].\n                  \n                  Repackaged/Relabeled by:\n                     Bryant Ranch Prepack, Inc.\n                     Burbank, CA 91504",
    "adverseReactions_original": "Pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. Angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see Warnings and Precautions (5.2)].",
    "drug": [
        {
            "name": "Pregabalin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64356"
        }
    ]
}